Dr. Farshad Moradi, MD, PhD

Dr. Moradi practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Moradi's NPI, 1225298581, was assigned on June 11, 2008. Dr. Moradi graduated from Tehran University of Medical Sciences School of Medicine in 2000. Dr. Moradi holds California license A119580.

Dr. Moradi's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Moradi's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Moradi is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Moradi to 2 more hospitals and 2 medical groups, each named with a free account. Dr. Moradi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moradi practices, 4 sites in all. Vendor and product names are available with a free account.

Nuclear radiology is Dr. Moradi's primary specialty in the NPI Registry, under taxonomy code 2085N0904X. Dr. Moradi is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dr. Moradi is licensed in California.

CMS data shows 1,537 Medicare services from Dr. Moradi across 14 procedure codes in 2024, for 1,393 Medicare patients. Medicare paid $103,124 for them.

CMS counts 1,393 Medicare patients who saw Dr. Moradi in 2024. The largest group is 65 to 74, with 619 patients. 74% of them have high cholesterol, and 68% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moradi's median patient age at 61, with 54% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Moradi for performance year 2024, reported as part of a group. Dr. Moradi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moradi as offering telehealth.

Dmand AI links 88 papers to Dr. Moradi, published from 2009 to 2024. 2020 was the busiest year, with 19. The most frequent topics are Positron Emission Tomography Computed Tomography, Positron-Emission Tomography and Magnetic Resonance Imaging. Dr. Moradi has published most often in J Nucl Med. Dr. Moradi's most frequent co-authors are Andrei Horia Iagaru, MD, Guido Alejandro Davidzon, MD, MS and Hong Song, MD.

Dmand AI links Dr. Moradi to 2 clinical trials. Conditions studied include Cholangitis, Sclerosing, Prostatic Neoplasms and Cholangitis.

CMS Open Payments shows 17 general payments to Dr. Moradi from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. GE Healthcare paid the most, $1,325.

Dr. Moradi graduated from Tehran University of Medical Sciences School of Medicine in 2000.

Dr. Moradi is in network with 3 carriers, including Excellus BlueCross BlueShield, CMS Medicare and NV State Medicaid. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.